One company's success demonstrates that there's hope for building truly integrated worldwide communications teams.
With one extraordinary product, Novartis showed how to make the most of relationships with patient advocacy groups.
Publicizing clinical trial results can backfire if companies fail to ask themselves the tough questions.
How Digital Medicine Can Pinpoint Dosing Regimens to Optimize Drug Efficacy and Safety
Sponsored By Oracle
Multi-faceted Approaches to Meet Payer and Regulatory Evidence Requirements
Sponsored By UBC Express Scripts
Overcoming the Life Sciences Content Conundrum in a Multichannel World
Sponsored By Veeva